Clearance Summary
FX Contra received FDA 510(k) clearance under submission number K222518, sponsored by Nakanishi, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2022-11-17.
- Submission: K222518
- Applicant / Sponsor: Nakanishi, Inc.
- Clearance pathway: Traditional
- Review panel: Dental
- Device class: Class I
- Regulation citation: 21 CFR 872.4200
- Decision date: 2022-11-17
Classification & Regulation
This clearance is catalogued under FDA product code EGS and 21 CFR 872.4200, within the Dental review panel as a Class I device.